Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Study of Iron Supplementation to Support the Response to Recombinant Human Erythropoietin for the Treatment of Chemotherapy-Induced Anaemia

NCT00482716 is registered in ClinicalTrials.gov with St. Bartholomew's Hospital as lead sponsor.

NCT NCT00482716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00482716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Study of Iron Supplementation to Support the Response to Recombinant Human Erythropoietin for the Treatment of Chemotherapy-Induced Anaemia
Lead sponsor
St. Bartholomew's Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2007
Completion date
Not reported
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, leukemia, lymphoma, multiple myeloma and plasma cell neoplasm, unspecified adult solid tumor, protocol specific